BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11765662)

  • 21. AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy.
    Cheung MC; Pantanowitz L; Dezube BJ
    Oncologist; 2005; 10(6):412-26. PubMed ID: 15967835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human immunodeficiency virus-related primary central nervous system lymphoma: factors influencing survival in 111 patients.
    Newell ME; Hoy JF; Cooper SG; DeGraaff B; Grulich AE; Bryant M; Millar JL; Brew BJ; Quinn DI
    Cancer; 2004 Jun; 100(12):2627-36. PubMed ID: 15197806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Population-based patterns of human immunodeficiency virus-related Hodgkin lymphoma in the Greater San Francisco Bay Area, 1988-1998.
    Glaser SL; Clarke CA; Gulley ML; Craig FE; DiGiuseppe JA; Dorfman RF; Mann RB; Ambinder RF
    Cancer; 2003 Jul; 98(2):300-9. PubMed ID: 12872349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved survival and chemotherapy response among patients with AIDS-related non-Hodgkin's lymphoma receiving highly active antiretroviral therapy.
    Diamond C; Taylor TH; Im T; Miradi M; Anton-Culver H
    Hematol Oncol; 2006 Sep; 24(3):139-45. PubMed ID: 16604565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decrease in the frequency of meningeal involvement in AIDS-related systemic lymphoma in patients receiving HAART.
    Navarro JT; Vall-Llovera F; Mate JL; Morgades M; Feliu E; Ribera JM
    Haematologica; 2008 Jan; 93(1):149-50. PubMed ID: 18166804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of HAART and calendar period on Kaposi's sarcoma and non-Hodgkin lymphoma: results of a match between an AIDS and cancer registry.
    Pipkin S; Scheer S; Okeigwe I; Schwarcz S; Harris DH; Hessol NA
    AIDS; 2011 Feb; 25(4):463-71. PubMed ID: 21139489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cumulative HIV viremia during highly active antiretroviral therapy is a strong predictor of AIDS-related lymphoma.
    Zoufaly A; Stellbrink HJ; Heiden MA; Kollan C; Hoffmann C; van Lunzen J; Hamouda O;
    J Infect Dis; 2009 Jul; 200(1):79-87. PubMed ID: 19476437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiretroviral treatment regimens and immune parameters in the prevention of systemic AIDS-related non-Hodgkin's lymphoma.
    Stebbing J; Gazzard B; Mandalia S; Teague A; Waterston A; Marvin V; Nelson M; Bower M
    J Clin Oncol; 2004 Jun; 22(11):2177-83. PubMed ID: 15169806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
    Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
    J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy.
    Polesel J; Clifford GM; Rickenbach M; Dal Maso L; Battegay M; Bouchardy C; Furrer H; Hasse B; Levi F; Probst-Hensch NM; Schmid P; Franceschi S;
    AIDS; 2008 Jan; 22(2):301-6. PubMed ID: 18097233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors associated with the occurrence of AIDS-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: Aquitaine Cohort, France.
    Bonnet F; Balestre E; Thiébaut R; Morlat P; Pellegrin JL; Neau D; Dabis F;
    Clin Infect Dis; 2006 Feb; 42(3):411-7. PubMed ID: 16392091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
    Bonnet F; Lewden C; May T; Heripret L; Jougla E; Bevilacqua S; Costagliola D; Salmon D; Chêne G; Morlat P
    Cancer; 2004 Jul; 101(2):317-24. PubMed ID: 15241829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Whole brain radiation alone produces favourable outcomes for AIDS-related primary central nervous system lymphoma in the HAART era.
    Nagai H; Odawara T; Ajisawa A; Tanuma J; Hagiwara S; Watanabe T; Uehira T; Uchiumi H; Yotsumoto M; Miyakawa T; Watanabe A; Kambe T; Konishi M; Saito S; Takahama S; Tateyama M; Okada S
    Eur J Haematol; 2010 Jun; 84(6):499-505. PubMed ID: 20132301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delayed progression to death and to AIDS in a Hong Kong cohort of patients with advanced HIV type 1 disease during the era of highly active antiretroviral therapy.
    Wong KH; Chan KC; Lee SS
    Clin Infect Dis; 2004 Sep; 39(6):853-60. PubMed ID: 15472819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of HAART in 254 consecutive patients with AIDS-related Kaposi's sarcoma.
    Bower M; Weir J; Francis N; Newsom-Davis T; Powles S; Crook T; Boffito M; Gazzard B; Nelson M
    AIDS; 2009 Aug; 23(13):1701-6. PubMed ID: 19550283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AIDS-related lymphomas--potentially curable in the HAART era.
    Valencia ME
    AIDS Rev; 2006; 8(2):108-10. PubMed ID: 16848278
    [No Abstract]   [Full Text] [Related]  

  • 37. The prognosis of HIV-infected patients with diffuse large B-cell lymphoma treated with chemotherapy and highly active antiretroviral therapy is similar to that of HIV-negative patients receiving chemotherapy.
    Navarro JT; Lloveras N; Ribera JM; Oriol A; Mate JL; Feliu E
    Haematologica; 2005 May; 90(5):704-6. PubMed ID: 15921395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The management of primary central nervous system lymphoma related to AIDS in the HAART era.
    González-Aguilar A; Soto-Hernández JL
    Curr Opin Oncol; 2011 Nov; 23(6):648-53. PubMed ID: 21946245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Profile of patients with Kaposi's sarcoma in the era of highly active antiretroviral therapy.
    Gallafent JH; Buskin SE; De Turk PB; Aboulafia DM
    J Clin Oncol; 2005 Feb; 23(6):1253-60. PubMed ID: 15718323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase II trial of infusional cyclophosphamide, doxorubicin, and etoposide in patients with HIV-associated non-Hodgkin's lymphoma: an Eastern Cooperative Oncology Group Trial (E1494).
    Sparano JA; Lee S; Chen MG; Nazeer T; Einzig A; Ambinder RF; Henry DH; Manalo J; Li T; Von Roenn JH
    J Clin Oncol; 2004 Apr; 22(8):1491-500. PubMed ID: 15084622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.